BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31571498)

  • 21. Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients.
    Martazanova B; Mishieva N; Vedikhina I; Kirillova A; Korneeva I; Ivanets T; Abubakirov A; Sukhikh GT
    Front Endocrinol (Lausanne); 2022; 13():834627. PubMed ID: 36046787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between hCG and GnRH Agonist for Ovulation Trigger in GnRH Antagonist In-Vitro Fertilization Cycles in a Tertiary Hospital in Malaysia: An observational study.
    Aziz NA; Ibrahim A; Ramli R; Yaacob N; Rahman SNA; Ismail EHE; Omar AA
    JBRA Assist Reprod; 2024 Feb; 28(1):21-26. PubMed ID: 38224580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The benefit of individualized low-dose hCG support for high responders in GnRHa-triggered IVF/ICSI cycles.
    Huang CY; Shieh ML; Li HY
    J Chin Med Assoc; 2016 Jul; 79(7):387-93. PubMed ID: 27147462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
    Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
    Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
    Lewit N; Kol S; Manor D; Itskovitz-Eldor J
    Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for the management of OHSS: Results from freezing-all cycles.
    Borges E; Braga DP; Setti AS; Vingris LS; Figueira RC; Iaconelli A
    JBRA Assist Reprod; 2016 Mar; 20(1):8-12. PubMed ID: 27203299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Dual Trigger with Combination of Gonadotropin-Releasing Hormone Agonist and Human Chorionic Gonadotropin in İmproving Oocyte-Follicle Ratio in Normo-Responder Patients.
    Gurbuz AS; Deveer R; Gode F
    Niger J Clin Pract; 2021 Aug; 24(8):1159-1163. PubMed ID: 34397024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes.
    Deepika K; Suvarna R; Sumi M; Snehal D; Arveen V; Anuja K; Gautham P; Kamini R
    JBRA Assist Reprod; 2021 Feb; 25(1):48-58. PubMed ID: 32960521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study.
    Haas J; Bassil R; Samara N; Zilberberg E; Mehta C; Orvieto R; Casper RF
    Hum Reprod; 2020 Jul; 35(7):1648-1654. PubMed ID: 32563188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study.
    Melo M; Busso CE; Bellver J; Alama P; Garrido N; Meseguer M; Pellicer A; Remohí J
    Reprod Biomed Online; 2009 Oct; 19(4):486-92. PubMed ID: 19909588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles.
    Gunnala V; Melnick A; Irani M; Reichman D; Schattman G; Davis O; Rosenwaks Z
    PLoS One; 2017; 12(4):e0176019. PubMed ID: 28441461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?
    Orvieto R
    J Ovarian Res; 2015 Aug; 8():60. PubMed ID: 26293447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial.
    Sismanoglu A; Tekin HI; Erden HF; Ciray NH; Ulug U; Bahceci M
    J Assist Reprod Genet; 2009 May; 26(5):251-6. PubMed ID: 19629674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadotropin-releasing hormone agonist (GnRHa) trigger - State of the art.
    Dosouto C; Haahr T; Humaidan P
    Reprod Biol; 2017 Mar; 17(1):1-8. PubMed ID: 28215488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
    Fatemi HM; Garcia-Velasco J
    Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS.
    Engmann L; Siano L; Schmidt D; Nulsen J; Maier D; Benadiva C
    Reprod Biomed Online; 2006 Nov; 13(5):639-44. PubMed ID: 17169172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.